The monoclonal antibodies 2H4 (antl-CD45RA) and UCHL1 (antl-CD45RO) were used to subdivide the CD4 and CD8 T-cell subsets into naive and memory cells. The peripheral blood lymphocytes of 34 patients with recent-onset IDDM, 21 patients with long-standing IDDM, and healthy control subjects of similar age and sex were analyzed by a three-color immunofluorescence technique. CD4 and CD8 lymphocytes expressed the CD45 isoforms alone (CD45RA+ or CD45RO+) or in combination (CD45RA+RO+). Simultaneous coexpression of both CD45RA and CD45RO (CD45RA+RO+) on CD4 and CD8 lymphocytes in patients with recent-onset IDDM was higher than in control subjects (P < 0.001). The proportion of CD4 lymphocytes expressing CD45RA alone (CD45RA+RO−) was similar in these groups, but the percentage of CD8 lymphocytes that were CD45RA+RO− was significantly higher in the patients with recent-onset IDDM (P < 0.05). The result of these changes is a significant increase in expression of naive phenotypes (CD45RA+ and CD45RA+RO+) on CD4 and CD8 lymphocytes in recent-onset IDDM (P < 0.005 and P < 0.0001). In long-standing IDDM, total CD45RA+ expression on CD4 and CD8 lymphocytes was reduced compared with control subjects (P < 0.05) as a result of a tendency of CD45RA+RO+ and CD45RA+RO+ subsets to be lower. This increase in total naive (CD45RA+) lymphocytes and in coexpression of naive (CD45RA) and memory (CD45RO) markers on CD4 and CD8 lymphocytes subsets In patients with recent-onset IDDM suggests that abnormal regulation of T-cell activation andmaturation is important in the pathogenesis of the disease.
Skip Nav Destination
Article navigation
Original Articles|
January 01 1993
Increase in Simultaneous Coexpression of Naive and Memory Lymphocyte Markers at Diagnosis of IDDM
Rebecca A Smerdon;
Rebecca A Smerdon
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Mark Peakman;
Mark Peakman
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Munther J Hussain;
Munther J Hussain
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Lorenzo Alviggi;
Lorenzo Alviggi
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Peter J Watkins;
Peter J Watkins
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
R David G Leslie;
R David G Leslie
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Diego Vergani
Diego Vergani
Department of Immunology and Diabetes, King's College School of Medicine and Dentistry, and the Diabetes Research Unit, Charing Cross and Westminster Medical School
London, United Kingdom
Search for other works by this author on:
Address correspondence and reprint requests to Professor Diego Vergani, Department of Immunology, King's College School of Medicine and Dentistry, London SE5 9PJ, UK.
Diabetes 1993;42(1):127–133
Article history
Received:
February 19 1992
Revision Received:
August 27 1992
Accepted:
August 27 1992
PubMed:
8420810
Citation
Rebecca A Smerdon, Mark Peakman, Munther J Hussain, Lorenzo Alviggi, Peter J Watkins, R David G Leslie, Diego Vergani; Increase in Simultaneous Coexpression of Naive and Memory Lymphocyte Markers at Diagnosis of IDDM. Diabetes 1 January 1993; 42 (1): 127–133. https://doi.org/10.2337/diab.42.1.127
Download citation file:
54
Views